+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mitsubishi Tanabe Pharma Corporation - logo

Mitsubishi Tanabe Pharma manufactures pharmaceuticals, primarily ethical drugs in Japan. It focuses on the fields of circulatory system and metabolism, neuropsychiatry, the respiratory system and immunology, and oncology and hepatology. It sells products such as anticoagulant Anplag, anti-allergy medicine Talion, liver drug Urso, and neuroprotective agent Radicut. The company was founded in 1901 and is headquartered in Osaka, Japan.

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Report 2025 - Product Thumbnail Image

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Anticoagulants Market Report 2025 - Product Thumbnail Image

Anticoagulants Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
Vasculitis - Pipeline Insight, 2025 - Product Thumbnail Image

Vasculitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Vaccines 2020: World Market Analysis, Players, Trends - Product Thumbnail Image

Vaccines 2020: World Market Analysis, Players, Trends

  • Report
  • November 2020
  • 217 Pages
  • Global
From
Herpangina Treatment Market Report 2025 - Product Thumbnail Image

Herpangina Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Toxoplasmosis Treatment Drugs Market Report 2025 - Product Thumbnail Image

Toxoplasmosis Treatment Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
TNF Alpha Inhibitors Market Report 2025 - Product Thumbnail Image

TNF Alpha Inhibitors Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
Histoplasmosis Treatment Market Report 2025 - Product Thumbnail Image

Histoplasmosis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
CCR Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CCR Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Poliomyelitis - Pipeline Insight, 2025 - Product Thumbnail Image

Poliomyelitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Angiotensin Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Angiotensin Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator